Probiotic products in Canada with clinical evidence: What can gastroenterologists recommend?, Pulsus Group Inc
       
  Pulsus Group Inc. The Medical Peer Review Publisher
                                                                                                                       
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
 
  Search The Canadian Journal of Gastroenterology
Search    
Advanced Search CONSUMER SITE
PROFESSIONAL SITE
 
 
 
 
THE CANADIAN JOURNAL OF GASTROENTEROLOGY
The Canadian Association of Gastroenterology (CAG) Canadian Association for the Study of the Liver (CASL)
                                                                                   
                                                                                   
                                                                                   
 
   Home   
   Current Issue   
   Past Issues   
   Guidelines   
   Supplements   
   Submit Manuscript   
   Calendar   
   Links   
 
 
 
Return to TOC
   PDF / Free   
 
Review February 2008, Volume 22 Issue 2: 169-175
 
Probiotic products in Canada with clinical evidence: What can gastroenterologists recommend?
G Reid, K Anukam, T Koyama

Probiotics, defined as 'live microorganisms, which when administered in adequate amounts, confer a health benefit on the host', are finally becoming an option for gastroenterologists in Canada, after being available for many years in Japan, Europe and the United States of America. Unfortunately, Health Canada and the US Food and Drug Administration have not controlled the use of the term 'probiotic' or put into place United Nations and World Health Organization guidelines. The net result is that a host of products are available called 'probiotics', that are not truly probiotic. The aim of the present review was to discuss the rationale for probiotics in gastroenterology, and specifically examine which products are options for physicians in Canada, and which ones patients might be using. It is hoped that by clarifying what probiotics are, and the strengths and limitations of their use, specialists will be better placed to make recommendations on the role of these products in patient care. In due course, more clinically documented probiotics will emerge, some with therapeutic effects based on a better understanding of disease processes.

   Français        E-Mail This Abstract To A Colleague
            Click here to download free Adobe PDF Reader
 
 
 
 
  Log in
  Register
  Survey
  Shopping Cart
Copyright © Pulsus Group Inc